ADXN
Addex Therapeutics Ltd
NASDAQ · Healthcare · Biotechnology · CH
$3.65
−1.62%Margins
Gross margin
-265.5%
EBITDA margin
-9539.0%
EBIT margin
-3630.8%
Net margin
-9410.2%
FCF margin
-3143.4%
-212.0%
Return on equity
-146.4%
Return on assets
-79.3%
Return on invested capital
0.01x
Asset turnover
-$2.9M
Cash from operations
$0.66
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026